Related Experiment Video
Updated: Jul 19, 2026

07:02
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
Tumour suppressor function of RNase L in a mouse model
Wendy Liu1, Shu-Ling Liang, Hongli Liu
1Department of Chemistry, Clinical Chemistry Program, Cleveland State University, 2121 Euclid Avenue, Cleveland, OH 44115, USA.
Summary
Ribonuclease L (RNase L) significantly slows fibrosarcoma tumor growth, even without interferon signaling. Overexpression of RNase L in cancer cells inhibited tumor formation and slowed growth in mice.
Area of Science:
- Molecular Biology
- Cancer Research
- Immunology
Background:
- RNase L is a key enzyme in interferon (IFN) pathways.
- It mediates antiviral, anti-proliferative, and pro-apoptotic functions.
- RNase L's role in tumor growth independent of IFN requires direct investigation.
Purpose of the Study:
- To investigate the direct effect of RNase L on fibrosarcoma tumor growth.
- To assess RNase L's anti-proliferative activity independent of other IFN-induced proteins.
Main Methods:
- Stable overexpression of human RNase L in mouse fibrosarcoma cells (P-57).
- Subcutaneous injection of RNase L-overexpressing cells (P-RL) and control cells (P-Vec) into nude mice.
- Monitoring of tumor volume, growth rate, and histological analysis.
Main Results:
- RNase L overexpression significantly delayed tumor formation and slowed tumor growth.
- Histological analysis showed increased polygonal cells and single-cell tumor necrosis in P-RL tumors.
- Tumors that resumed growth after initial inhibition no longer expressed ectopic RNase L.
Conclusions:
- RNase L plays a critical role in inhibiting fibrosarcoma growth.
- RNase L exhibits anti-tumorigenic properties independent of interferon.
- Loss of RNase L expression may contribute to tumor regrowth.
Related Concept Videos
Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
lncRNA - Long Non-coding RNAs
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
In-vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
